Skip to main content

Advertisement

Table 1 Clinical variables

From: Systemic vascular function, measured with forearm flow mediated dilatation, in acute and stable cerebrovascular disease: a case-control study

  Recent Stroke/TIA n = 17 Stable Disease n = 17 p
Gender, n = F 6 (35%) 6 (35%)  
Age at FMD scan, years 64.2 ± 13.0 64.7 ± 11.7 0.23
Medical History    
Myocardial Infarction 2 (12%) 1 (6%) 1.0
Hypertension 15 (89%) 15 (89%) 1.0
Hypercholesterolaemia 11 (65%) 12 (71%) 0.71
Diabetes 2 (12%) 3 (18%) 1.0
Smoking 9 (53%) 9 (53%) 1.0
Prior Therapy    
Antihypertensive 12 (71%) 14 (83%) 0.6
Lipid Lowering 12 (71%) 11 (65%) 0.72
Clinical Variables    
Clinical Syndrome TACS 1 (6%) 2 (12%)  
PACS 6 (35%) 4 (24%)  
LACS 4 (24%) 6 (35%)  
POCS 2 (12%) 1 (6%)  
TIA 4 (24%) 4 (24%)  
SBP, mmHg 139.9 ± 21.0 138.9 ± 18.7 0.86
DBP, mm Hg 84.1 ± 13.6 79.6 ± 14.7 0.21
Cholesterol, mmolL-1 3.9 ± 0.9 4.2 ± 0.9 0.44
Triglycerides, 1.1 ± 0.3 1.3 ± 0.5 0.25
HDL, mmolL-1 2.1 ± 1.1 2.2 ± 0.6 0.77
LDL, mmolL-1 1.3 ± 0.5 1.4 ± 0.6 0.52
  1. Data are N (%) or N ± SD; TACI = Total Anterior Circulation, PACI = Partial Anterior Circulation, LACI = Lacunar, TIA = Transient Ischaemic attack; S(D)BP = Systolic (Diastolic) Blood Pressure; H(L)DL = High (Low) Density Lipoprotein